| http://www.w3.org/ns/prov#value | - as measured by lower pain scores and longer latency times to analgesic administration Harm: No adverse events in all randomized controlled trials except one, which reported increased hemorrhage as a secondary outcome unadjusted for other risk factors Cost: Direct cost of medication and indirect costs of drug administration Benefits-harm assessment: Preponderance of benefit over harm Value judgment
|
